ஆண்டு அறிவியல் அமர்வு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆண்டு அறிவியல் அமர்வு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆண்டு அறிவியல் அமர்வு Today - Breaking & Trending Today

Statins Do Not Improve COVID-19 Outcomes, Study Shows


Adobe Stock
Early on in the pandemic, doctors reported that patients who were critically ill with COVID-19 appeared to have a higher risk of blood clots. And there was speculation that statins a type of cholesterol-lowering drug could help. Research conducted in New York City and published in February 2021 in the journal
found that people who had been taking statins long-term before being hospitalized with COVID-19 were 50 percent less likely to die within 30 days compared with those who hadn’t. The researchers hypothesized that this may have something to do with statins’ anti-inflammatory effect, which they thought may be effective in treating inflammation-related complications of COVID-19. ....

New York , United States , Behnood Bikdeli , Michael Tran , Nature Communications , American College Of Cardiology , New York City , American College , Annual Scientific Session , Cleveland Clinic , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , மைக்கேல் டிரான் , இயற்கை தகவல்தொடர்புகள் , அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் , புதியது யார்க் நகரம் , அமெரிக்கன் கல்லூரி , ஆண்டு அறிவியல் அமர்வு , கிளீவ்லேண்ட் சிகிச்சையகம் ,

Why Amarin Trounced the Market on Tuesday


Author Bio
Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.
What happened
Amarin (NASDAQ:AMRN) rose to end Tuesday nearly 5.1% higher after the company provided details from clinical studies of the components of its one commercialized drug.
So what
In a presentation at the American College of Cardiology s Annual Scientific Session, Amarin presented findings from a study of a key ingredient of that drug, cardiovascular treatment Vascepa (marketed as Vazkepa in the EU).  ....

Steven Ketchum , American College Of Cardiology Annual Scientific Session , American College , Annual Scientific Session , Chief Scientific Officer Steven Ketchum , ஸ்டீவன் கெட்சம் , அமெரிக்கன் கல்லூரி ஆஃப் இருதயவியல் ஆண்டு அறிவியல் அமர்வு , அமெரிக்கன் கல்லூரி , ஆண்டு அறிவியல் அமர்வு ,